REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Auxilium Pharmaceuticals, Inc. (NQ: AUXL)
15.24 USD  +0.11 (+0.73%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Auxilium Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference
May 15, 2013
from PR Newswire
Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
May 10, 2013
from PR Newswire
GTCR Announces Sale of Actient to Auxilium Pharmaceuticals
April 29, 2013
from Business Wire News Releases
Auxilium Pharmaceuticals, Inc, Announces First Quarter 2013 Financial Results
April 29, 2013
- 1Q13 Net Revenues Decreased by 10% from 1Q12 to $66.2 MM - Read More
from PR Newswire
Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
April 29, 2013
-Transaction Expected to be Immediately Accretive to Adjusted Non-GAAP Net Income- Read More
from PR Newswire
Auxilium Pharmaceuticals to Announce First Quarter 2013 Results and Conduct Conference Call on Monday, April 29, 2013
April 25, 2013
from PR Newswire
Auxilium Pharmaceuticals, Inc. Announces Positive Top-line Data from XIAFLEX® (CCH) Frozen Shoulder Syndrome Phase IIa Study
March 25, 2013
- Statistically Significant Improvements in Range of Motion Compared to Exercise-Only Arm and Dose Response Supports Progression into Placebo-controlled Studies - Read More
from PR Newswire
Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
March 04, 2013
from PR Newswire
Trends in the Drug Related Products Industry
February 27, 2013
The ShinesRooms.com Provides Stock Research on Herbalife Ltd. and Auxilium Pharmaceuticals Inc. Read More
from Marketwired News Releases
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
February 26, 2013
- 2012 Marks First Full Year of Profitability - Read More
from PR Newswire
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Results and Conduct Conference Call on Tuesday, February 26, 2013
February 12, 2013
from PR Newswire
Auxilium Pharmaceuticals, Inc. to Present at the Leerink Swann Global Healthcare Conference
February 12, 2013
from PR Newswire
Auxilium Pharmaceuticals, Inc. Announces IMPRESS Trials of XIALFEX® in Peyronie's Disease Were Published Online in The Journal of Urology
February 01, 2013
from PR Newswire
Auxilium Pharmaceuticals, Inc. Announces Issuance of $350.0 Million of 1.50% Convertible Senior Notes Due 2018
January 30, 2013
from PR Newswire
Auxilium Pharmaceuticals, Inc. and Xstelos Holdings, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim® Patents
January 28, 2013
from PR Newswire
Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
January 25, 2013
from PR Newswire
Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
January 23, 2013
from PR Newswire
Auxilium Pharmaceuticals Streamlines Copy Approval Process with Vault PromoMats, Veeva Systems’ Cloud-Based Content Management Application
January 08, 2013
from Business Wire News Releases
Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX® (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication
January 07, 2013
from PR Newswire
Auxilium Pharmaceuticals to Present at the J.P. Morgan 2013 Healthcare Conference
January 03, 2013
from PR Newswire
Auxilium Pharmaceuticals, Inc. and Xstelos Holdings, Inc. Receive 505(b)(2) Paragraph IV Certification Notice from Upsher-Smith Laboratories, Inc. for Testim®
January 03, 2013
from PR Newswire
U.S. Food and Drug Administration Accepts XIAFLEX® Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
December 27, 2012
from PR Newswire
Auxilium Pharmaceuticals Announces Encouraging Top-line 30-Day Data from XIAFLEX® (CCH) Phase Ib Study in Cellulite
December 13, 2012
- Data Supports Progression into Phase II; All Doses Were Generally Well-tolerated - Read More
from PR Newswire
Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth Conference
December 07, 2012
from PR Newswire
Analyst Opinion on Perrigo Co. and Auxilium Pharmaceuticals Inc. - Drug Related Product Companies Remain Healthy
November 13, 2012
from Marketwired News Releases
NuPathe Announces Third Quarter 2012 Financial Results and Operational Highlights
November 12, 2012
from Marketwired News Releases
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
November 07, 2012
- 3Q12 Total Net Revenues Increased by 6% vs. 3Q11 to $71.0 MM - Read More
from PR Newswire
Auxilium and Pfizer Will Conclude Agreement on XIAPEX® EU Collaboration
November 07, 2012
from PR Newswire
Auxilium Pharmaceuticals, Inc. Submits Supplemental Biologics License Application to the FDA for XIAFLEX® for the Treatment of Peyronie's Disease
November 07, 2012
from PR Newswire
Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
November 01, 2012
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here